Skip to main content
OpenTrials

Clinical trial condition

Hemoglobinuria, Paroxysmal

Explore clinical trials studying Hemoglobinuria, Paroxysmal. Study availability and eligibility vary by location and protocol.

159 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Hemoglobinuria, Paroxysmal trial results

Completed

Ravulizumab Subcutaneous (SC) Versus Ravulizumab Intravenous (IV) in Adults With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

NCT03748823

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Liverpool, Australia
  • Research Site Parkville, Australia
  • Research Site Vienna, Austria
View all 51 locations
View Trial Details
Completed

Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Study, Assessing Multiple LNP023 Doses in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria

NCT03896152

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +8 more
Locations
  • Novartis Investigative Site Kota Kinabalu, Sabah, Malaysia
  • Novartis Investigative Site Singapore
  • Novartis Investigative Site Seoul, South Korea
  • Novartis Investigative Site Seoul, South Korea
View Trial Details
Completed

ALXN1210 (Ravulizumab) Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT02946463

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Whittier, California, United States
  • Research Site Fort Worth, Texas, United States
  • Research Site Buenos Aires, Argentina
View all 120 locations
View Trial Details
Completed

A Study to Compare SB12 (Proposed Eculizumab Biosimilar) to Soliris in Subjects With Paroxysmal Nocturnal Haemoglobinuria

NCT04058158

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Fortis Memorial Research Institute Gurgaon, Haryana, India
  • Post Graduate Institute of Medical Education and Research (PGIMER) Chandigarh, India
  • Apollo Hospitals International Limited Chennai, India
  • Amrita Institute of Medical Sciences and Research Centre Kochi, India
View all 27 locations
View Trial Details
Completed

Prospective Observational Study of Long-term Pathogenic Treatment of Elizaria®

NCT04671810

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • State budgetary healthcare institution "Chelyabinsk Regional Clinical Hospital" Chelyabinsk, Chelyabinsk Oblast, Russia
  • State Budgetary Institution of Healthcare Irkutsk Order of the "Badge of Honor" Regional Clinical Hospital Irkutsk, Irkutsk Oblast, Russia
  • State Budgetary Institution of Healthcare of the City of Moscow City Clinical Hospital named after S.P. Botkin of the Moscow Department of Health Moscow, Moscow Oblast, Russia
  • Federal State Budgetary Educational Institution of Higher Education "Novosibirsk State Medical University" of the Ministry of Health of the Russian Federation on the basis of the State Budgetary Institution of Health of the Novosibirsk Region "City Clinic Novosibirsk, Novosibirsk Oblast, Russia
View Trial Details

Related conditions